4-Chloro-3-fluorophenylacetic acid

We are 4-Chloro-3-fluorophenylacetic acid CAS:883500-51-4 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:4-Chloro-3-fluorophenylacetic acid
CAS.NO:883500-51-4
Synonyms:4-Chloro-3-fluorophenylacetic acid
2-(4-Chloro-3-fluorophenyl)acetic acid
(4-Chloro-3-fluorophenyl)acetic acid
 
Physical and Chemical Properties:
Density 1.4±0.1 g/cm3
Boiling Point 293.1±25.0 °C at 760 mmHg
Melting Point 88-91℃
Molecular Formula C8H6ClFO2
Molecular Weight 188.583
Flash Point 131.1±23.2 °C
Vapour Pressure 0.0±0.6 mmHg at 25°C
Index of Refraction 1.548
 
Specification:
Appearance:White to off-white powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Organic synthesis.

4-Chloro-3-fluorophenylacetic acid


Related News: Mankind Pharmaceuticals on Monday said it has inked a licensing pact with Glenmark Pharmaceuticals to co-market diabetes drug Remogliflozin Etabonate in the country.Clorhidrato de ácido 4-guanidinobenzoico CAS:42823-46-1 Any US citizen who has been in China’s Hubei province — epicenter of the outbreak — in the last 14 days will be allowed back into the country.3-Phenoxy-benzaldehyde Multinational drugmakers usually cut the price of drugs when they go off-patent and face competition from generic versions, but such price drops were slow to happen in China, partially because many local drugmakers were unable to develop high-quality generic drugs to compete with off-patent branded drugs.2-Methoxy-5-(trifluoromethyl)benzonitrile Multinational drugmakers usually cut the price of drugs when they go off-patent and face competition from generic versions, but such price drops were slow to happen in China, partially because many local drugmakers were unable to develop high-quality generic drugs to compete with off-patent branded drugs.Different cell types can be affected, although the most common finding in MDS is a shortage of red blood cells (anaemia). Patients with higher-risk MDS may progress to the development of acute leukaemia.

Related Products
Product Name
2-Bromo-4-fluoropyridine View Details
2,4-Dimethyl aniline View Details
CAS:3896-11-5 BASF TINUVIN 326 View Details
Glycine manufacturer 2,6-Dibromonaphthalene manufacturer CAS:88-04-0 4-Chloro-3,5-xylenol manufacturer 3-Morpholino-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one manufacturer 11-(1-Piperazinyl)-Dibenzo[b,f][1,4]Thiazepine Dihydrochloride manufacturer